Seeking Alpha

Ginkgo Bioworks Acquires Reverie Labs Platform, Enhancing AI-Driven Drug Discovery Capabilities for Customer Programs

BOSTON, Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of key assets of Reverie Labs ...
Seeking Alpha

Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"

BOSTON, April 11, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (DNA) (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its 5th annual Ferment ...
Nasdaq

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

BOSTON, Feb. 21, 2025 /PRNewswire/ -- Volta Labs, a leading genomics applications company, and Ginkgo Bioworks, (NYSE: DNA), which is building a leading platform for cell programming and biosecurity, ...
WOOD-TV

Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International ...

BOSTON, July 17, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the launch of a powerful new capability ...
Forbes

Creative Residents Ask ‘Why’ And ‘What If’ At Ginkgo Bioworks

Forbes contributors publish independent expert analyses and insights. Benjamin Wolff covers leadership insights from the world of the arts. A new technology is changing the world, turning dreams into ...